ClinConnect ClinConnect Logo
Search / Trial NCT03056391

Effect of Paracetamol on Renal Function in Plasmodium Knowlesi Malaria

Launched by MENZIES SCHOOL OF HEALTH RESEARCH · Feb 14, 2017

Trial Information

Current as of June 15, 2025

Completed

Keywords

Knowlesi Malaria Paracetamol Renal Function Haemolysis Oxidative Stress

ClinConnect Summary

Plasmodium knowlesi is the most common cause of malaria, and malaria deaths, in Sabah, Malaysia. Acute kidney injury (AKI) is a common feature of severe knowlesi malaria; however the mechanisms of AKI in knowlesi malaria are unknown. In falciparum malaria, recent evidence suggests that oxidative stress from haemolysis-related cell-free haemoglobin (CFHb) may contribute to pathogenesis of AKI.

Cell-free haemoglobin and oxidative stress: CFHb is released during intravascular haemolysis, and when exceeding the binding capacity of plasma haptoglobin, is filtered by the glomeruli and enters the...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patient age ≥ 5 years
  • 2. Presence of P. knowlesi malaria, confirmed by positive blood smear with asexual forms of P. knowlesi.
  • 3. Temperature \>38C on admission or fever during the preceding 48 hours
  • 4. Enrolled within 18 hours of commencing antimalarial treatment
  • 5. Written informed consent from patient or attending relative able to and willing to give informed consent. Consent form and information sheets will be translated into Malay and copies provided to the patient.
  • Exclusion Criteria:
  • 1. Patient or relatives unable or unwilling to give informed consent
  • 2. Contraindication or allergy to paracetamol or artesunate therapy
  • 3. Known cirrhosis, or \>6 standard alcoholic drinks/day
  • 4. Pregnancy

About Menzies School Of Health Research

The Menzies School of Health Research is a leading research institution dedicated to improving health outcomes through innovative research and education. Based in Australia, Menzies focuses on key areas such as infectious diseases, chronic conditions, and Indigenous health, leveraging interdisciplinary approaches to address complex health challenges. With a commitment to translating research findings into practical applications, Menzies collaborates with local communities, health organizations, and policymakers to enhance healthcare delivery and promote health equity. Through its robust clinical trial programs, Menzies aims to advance scientific knowledge and contribute to evidence-based practices that benefit diverse populations.

Locations

Kota Kinabalu, Sabah, Malaysia

Keningau, Sabah, Malaysia

Kota Marudu, Sabah, Malaysia

Ranau, Sabah, Malaysia

Patients applied

0 patients applied

Trial Officials

Giri M Rajahram, MD

Principal Investigator

Clinical Research Center, Queen Elizabeth Hospital, Kota Kinabalu, Sabah, Malaysia

Bridget Barber, MBBS

Study Director

Menzies School of Health Research

Nicholas Anstey, PhD

Study Director

Menzies School of Health Research

Matthew Grigg, MBBS

Study Director

Menzies School of Health Research

Timothy William, MBBS

Study Director

Jesselton Medical Centre

Jayaram Menon, MBBS

Study Director

Ministry of Health, Malaysia

Tsin Yeo, MBBS

Study Director

Menzies School of Health Research

Katherine Plewes, MD

Study Director

Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand

Arjen Dondorp, MD

Study Director

Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand

Daniel Cooper, MBChB

Study Director

Menzies School of Health Research

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials